MLL
DPLO

Moody Lynn & Lieberson’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Moody Lynn & Lieberson’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-14,494
Closed -$406K – 189
2016
Q3 		$406K Sell
14,494
-611
-4% -$20.5K 0.07% 130
2016
Q2 		$529K Buy
15,105
+190
+1% +$5.97K 0.09% 95
2016
Q1 		$409K Sell
14,915
-425
-3% -$12.5K 0.06% 121
2015
Q4 		$525K Buy
15,340
+307
+2% +$9.58K 0.08% 119
2015
Q3 		$432K Buy
15,033
+2,815
+23% +$120K 0.08% 117
2015
Q2 		$547K Buy
12,218
+427
+4% +$16.1K 0.09% 115
2015
Q1 		$408K Buy
+11,791
New +$321K 0.07% 118

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Moody Lynn & Lieberson's DPLO Position: Q4 2016 in Review

Moody Lynn & Lieberson sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 14,494 shares — an estimated $406K sold.

Moody Lynn & Lieberson first reported a position in DPLO in Q1 2015 and held it in 7 quarters. The position peaked at $547K in Q2 2015. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • Moody Lynn & Lieberson reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 14,494 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $406K.
  • Moody Lynn & Lieberson first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 7 quarters.
  • Moody Lynn & Lieberson's DIPLOMAT PHARMACY, INC. position peaked at $547K in Q2 2015.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2016, filed 25 Jan 2017.